Published in Phys Med Biol on June 15, 2012
Development of phase-contrast X-ray imaging techniques and potential medical applications. Phys Med (2008) 1.58
Dose prescription and optimisation based on tumour hypoxia. Acta Oncol (2009) 0.98
Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Radiobiological study of 65 consecutive patients. Strahlenther Onkol (2005) 0.91
Three-dimensional atlas of lymph node topography based on the visible human data set. Anat Rec B New Anat (2006) 0.90
Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol (2003) 0.90
Dose prescription and treatment planning based on FMISO-PET hypoxia. Acta Oncol (2011) 0.89
Analytical expressions for water-to-air stopping-power ratios relevant for accurate dosimetry in particle therapy. Phys Med Biol (2011) 0.88
Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams. Med Phys (2007) 0.87
Dependence of simulated positron emitter yields in ion beam cancer therapy on modeling nuclear fragmentation. Appl Radiat Isot (2013) 0.84
Biological response to radiation therapy. Acta Oncol (2003) 0.84
Effects of positioning uncertainty and breathing on dose delivery and radiation pneumonitis prediction in breast cancer. Acta Oncol (2002) 0.84
The radiation response of heterogeneous tumors. Phys Med (2007) 0.84
Quantifying tumour hypoxia by PET imaging--a theoretical analysis. Adv Exp Med Biol (2009) 0.83
The clinical value of non-coplanar photon beams in biologically optimized intensity modulated dose delivery on deep-seated tumours. Acta Oncol (2003) 0.82
Variation in radiation sensitivity and repair kinetics in different parts of the spinal cord. Acta Oncol (2008) 0.81
Design of a fast multileaf collimator for radiobiological optimized IMRT with scanned beams of photons, electrons, and light ions. Med Phys (2007) 0.80
Ion beam transport in tissue-like media using the Monte Carlo code SHIELD-HIT. Phys Med Biol (2004) 0.80
Prognostic significance of intratumour microvessel density and haemoglobin level in carcinoma of the uterine cervix. Acta Oncol (2002) 0.80
Fluence correction factors and stopping power ratios for clinical ion beams. Acta Oncol (2011) 0.79
Prediction of AVM obliteration after stereotactic radiotherapy using radiobiological modelling. Phys Med Biol (2002) 0.78
Investigation of the added value of high-energy electrons in intensity-modulated radiotherapy: four clinical cases. Int J Radiat Oncol Biol Phys (2002) 0.77
Statistical methods for clinical verification of dose-response parameters related to esophageal stricture and AVM obliteration from radiotherapy. Phys Med Biol (2004) 0.77
Comparison of dose response models for predicting normal tissue complications from cancer radiotherapy: application in rat spinal cord. Cancers (Basel) (2011) 0.77
Development of high-resolution molecular phase-contrast stereoscopic X-ray imaging for accurate cancer diagnostics. Radiat Prot Dosimetry (2010) 0.77
Optimizing SHIELD-HIT for carbon ion treatment. Phys Med Biol (2012) 0.76
Clinical and radiobiological advantages of single-dose stereotactic light-ion radiation therapy for large intracranial arteriovenous malformations. Technical note. J Neurosurg (2009) 0.75
Radiation transport calculations for 50 MV photon therapy beam using the Monte Carlo code GEANT4. Radiat Prot Dosimetry (2005) 0.75
D, an effective uniform dose linked to the probability of response. Phys Med Biol (2002) 0.75
The dose--response relation for rat spinal cord paralysis analyzed in terms of the effective size of the functional subunit. Phys Med Biol (2008) 0.75
Simulation of secondary particle production and absorbed dose to tissue in light ion beams. Radiat Prot Dosimetry (2005) 0.75
Cancer incidence and radiation therapy in Mozambique - a comparative study to Sweden. Acta Oncol (2013) 0.75
Secondary absorbed doses from light ion irradiation in anthropomorphic phantoms representing an adult male and a 10 year old child. Phys Med Biol (2010) 0.75
Cellular parameters and RBE-LET dependences for modelling heavy-ion radiotherapy. Radiother Oncol (2004) 0.75
Vascular structure and binomial statistics for response modeling in radiosurgery of cerebral arteriovenous malformations. Phys Med Biol (2010) 0.75
Fast IMRT with narrow high energy scanned photon beams. Med Phys (2011) 0.75
Recent improvements in the SHIELD-HIT code. Int J Radiat Biol (2011) 0.75
A Monte Carlo evaluation of carbon and lithium ions dose distributions in water. Int J Radiat Biol (2012) 0.75
Development of light ion therapy at the Karolinska Hospital and Institute. Radiother Oncol (2004) 0.75
Energy-range relation and mean energy variation in therapeutic particle beams. Med Phys (2008) 0.75
Clinical application of in vivo treatment delivery verification based on PET/CT imaging of positron activity induced at high energy photon therapy. Phys Med Biol (2013) 0.75
Swedish Cancer Society radiation therapy research investigation. Acta Oncol (2002) 0.75
Effective beam directions using radiobiologically optimized IMRT of node positive breast cancer. Phys Med (2007) 0.75
Simulations of microdosimetric quantities with the Monte Carlo code FLUKA for carbon ions at therapeutic energies. Int J Radiat Biol (2011) 0.75
Monte Carlo simulations on the water-to-air stopping power ratio for carbon ion dosimetry. Med Phys (2009) 0.75
Radial secondary electron dose profiles and biological effects in light-ion beams based on analytical and Monte Carlo calculations using distorted wave cross sections. Radiat Res (2008) 0.75
Secondary particle production in tissue-like and shielding materials for light and heavy ions calculated with the Monte-Carlo code SHIELD-HIT. J Radiat Res (2002) 0.75
The impact of modeling nuclear fragmentation on delivered dose and radiobiology in ion therapy. Phys Med Biol (2012) 0.75
Radiation therapy dose delivery. Acta Oncol (2003) 0.75